Topic: Indianapolis

Lilly will not seek FDA approval for arzoxifene

AP Features - 903 days ago
Eli Lilly & Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal osteoporosis drug because of certain study results and safety concerns.The company said the drug met its late-stage study goals of reducing the risk ...
Read More...

Clinical Trials Update: May 29, 2009

Drugs.com - 984 days ago
Here are the latest clinical trials, courtesy of ClinicalConnection. The research site is in Sacramento, Calif.. The research site is in Edina, Minn.. If you are an adult with untreated diffuse large B-cell or follicular non-Hodgkin's lymphoma, you may qualify for this ...